 II. To determine the response rates in patients with measurable disease by Response Evaluation Criteria in Solid Tumors RECIST version 1.1 for each different disease pancreatic cancer, biliary tract cancer, esophagealgastric cancer, adenocarcinoma of unknown primary treated in the study. 